Genmab | GEN - Dividendenrendite

Aktienkurs
1,637.00
Täglich Wechseln
-8.00 -0.49%
Monatlich
-10.67%
Jährlich
20.06%
Q1 Prognose
1,614.31




Dy Veränderung Datum
Amgen 2.95 0.38 2025-12
argenx SE USD 0 0 2025-03
AstraZeneca USD 1.74 0.4 2025-12
Bayer 0.3 0.09 2025-12
Demant 0 0 2024-12
Fresenius Medical Care 3.53 0.31 2025-12
Galapagos 0 0 2025-03
Genmab 0 0 2025-03
GlaxoSmithKline 4.57 1.52 2025-12
GN Store Nord 0.97 0.19 2022-12
GRIFOLS 1.92 0.17 2025-12
Hikma Pharmaceutical USD 4.02 1.1 2025-12
Lonza 0.74 0.04 2025-12
Merck 1.8 0.22 2025-12
Novartis USD 3.05 0.26 2025-12
Regeneron Pharmaceuticals 0.46 0.01 2025-12
Roche Holding 2.96 0.8 2025-12
Sanofi 4.74 0.25 2025-12
UCB 0.58 0.25 2025-12